These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19443433)

  • 21. Effect of atrial fibrillation pattern on survival in a community-based cohort.
    Keating RJ; Gersh BJ; Hodge DO; Weivoda PL; Patel PJ; Hammill SC; Shen WK
    Am J Cardiol; 2005 Nov; 96(10):1420-4. PubMed ID: 16275191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-level incidence and risk factors for pulmonary toxicity associated with amiodarone.
    Jackevicius CA; Tom A; Essebag V; Eisenberg MJ; Rahme E; Tu JV; Humphries K; Behlouli H; Pilote L
    Am J Cardiol; 2011 Sep; 108(5):705-10. PubMed ID: 21704281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal changes in patient characteristics and prior pharmacotherapy in patients undergoing radiofrequency ablation of atrial fibrillation: a Danish nationwide cohort study.
    Karasoy D; Gislason GH; Hansen J; Olesen JB; Torp-Pedersen C; Johannessen A; Hansen ML
    Europace; 2013 May; 15(5):669-75. PubMed ID: 23284140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of amiodarone dose on the risk of permanent pacemaker insertion.
    Essebag V; Hadjis T; Platt RW; Abrahamowicz M; Pilote L
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1519-25. PubMed ID: 15546307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation.
    Sharma S; Gage BF; Deych E; Rich MW
    Am Heart J; 2009 Jun; 157(6):1057-63. PubMed ID: 19464417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
    Hohnloser SH; Connolly SJ; Crijns HJ; Page RL; Seiz W; Torp-Petersen C
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):69-73. PubMed ID: 18031520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
    Kaufman ES; Zimmermann PA; Wang T; Dennish GW; Barrell PD; Chandler ML; Greene HL;
    J Am Coll Cardiol; 2004 Sep; 44(6):1276-82. PubMed ID: 15364332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
    Piccini JP; Al-Khatib SM; Wojdyla DM; Shaw LK; Horton JR; Lokhnygina Y; Anstrom KJ; DeWald T; Allen-LaPointe N; Steinberg BA; Thomas K; Daubert JP; Peterson ED
    Am J Cardiol; 2014 Sep; 114(5):716-22. PubMed ID: 25129065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
    Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
    Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Hamilos ME; Marketou ME; Chlouverakis GI; Vardas PE
    Am J Cardiol; 2007 Jun; 99(12):1721-5. PubMed ID: 17560882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation.
    Hansen ML; Gadsbøll N; Rasmussen S; Gislason GH; Folke F; Andersen SS; Schramm TK; Sørensen R; Fosbøl EL; Abildstrøm SZ; Madsen M; Poulsen HE; Køber L; Torp-Pedersen C
    J Intern Med; 2009 Mar; 265(3):335-44. PubMed ID: 19141096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study.
    Miyasaka Y; Barnes ME; Bailey KR; Cha SS; Gersh BJ; Seward JB; Tsang TS
    J Am Coll Cardiol; 2007 Mar; 49(9):986-92. PubMed ID: 17336723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiarrhythmic drugs in atrial fibrillation].
    Brembilla-Perrot B
    Rev Prat; 2002 Jun; 52(12):1317-23. PubMed ID: 12187895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trend in mortality after stroke with atrial fibrillation.
    Frost L; Andersen LV; Vestergaard P; Husted S; Mortensen LS
    Am J Med; 2007 Jan; 120(1):47-53. PubMed ID: 17208079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
    Men EE; Yildirimtürk O; Tuğcu A; Aytekin V; Aytekin S
    Anadolu Kardiyol Derg; 2008 Jun; 8(3):206-12. PubMed ID: 18524727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
    Schrickel JW; Schwab JO; Yang A; Bielik H; Bitzen A; Lüderitz B; Lewalter T
    Europace; 2006 Jun; 8(6):403-7. PubMed ID: 16687421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
    Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation].
    He R; Du X; Liu SW; Sun LJ; Li Y; Zeng H; Li YY; Sun C; Zhang Y; Ma CS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):935-939. PubMed ID: 27903390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.